Showing results (181-190 of 219) with videos related to
Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed GlioblastomaMary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, et al.The Oncologist|August 24, 2023
A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System TumorsJames F Haberberger, Worthy Pegram, Nicholas Britt, et al.Neuro-Oncology|January 31, 2016
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningiomaMalak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, et al.The Lancet. Oncology|October 31, 2024
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practiceSpyridon Bakas, Philipp Vollmuth, Norbert Galldiks, et al.Neuro-Oncology|February 3, 2026
Meningioma microenvironment harbors a rich immune landscape that evolves with biological stateXiaopeng Guo, Zachary A Moynihan, Joseph Driver, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2023
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent GlioblastomaGilbert Youssef, Rifaquat Rahman, Camden Bay, et al.The Lancet. Oncology|October 31, 2024
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancementsJavier E Villanueva-Meyer, Spyridon Bakas, Pallavi Tiwari, et al.Cancer Cell|July 11, 2018
Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic DevelopmentZev A Binder, Amy Haseley Thorne, Spyridon Bakas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2017
Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR ImagingKen Chang, Harrison X Bai, Hao Zhou, et al.Frontiers in Neural Circuits|June 26, 2026
A modular and flexible pipeline for intraoperative electrode reconstruction and localization in patients with brain lesionsHaziq Rabbani, Ipsita Das, Ayan S Mandal, et al.Pageof 22